Analysis of the clinicopathological characteristics and prognosis of triple-positive breast cancer and HER2-positive breast cancer—A retrospective study

Analysis of the clinicopathological characteristics and prognosis of triple-positive breast cancer and HER2-positive breast cancer—A retrospective study

BackgroundAdjuvant chemotherapy and targeted therapy have become standard postoperative therapeutic modalities for human epidermal growth factor receptor 2 (HER2)-positive breast cancer(HER2-positive,HR-negative), including triple-positive breast cancer(HER2-positive,HR-positive). However, these two...

Full description

Bibliographic Details
Main Authors: Dongxu Ma, Qing Yang, Ke Yin, Peng Shi, Xiao Chen, Tianyi Dong, Xingchen Shang, Xingsong Tian
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
triple-positive breast cancer
HER2-positive breast cancer
clinicopathological characteristics
prognosis
hormone receptors
adjuvant chemotherapy
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.999894/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.999894/full

Similar Items